{"url_path":"/sec/okyo/10-k/2026/item-16j","section_key":"item-16j","section_title":"Item 16J INSIDER TRADING POLICIES**","topic":"sec","document":{"doc_type":"20-F","doc_date":"2026-07-20","source_url":"https://www.sec.gov/Archives/edgar/data/1849296/0001493152-26-033847-index.html","accession_number":"0001493152-26-033847","cik":"0001849296","ticker":"OKYO","issuer_name":"OKYO Pharma Ltd","edgar_url":"https://www.sec.gov/Archives/edgar/data/1849296/0001493152-26-033847-index.html","primary_entity_key":"0001849296","primary_entity_name":"OKYO Pharma Ltd"},"word_count":93,"has_tables":true,"body_markdown":"**ITEM\n16J: INSIDER TRADING POLICIES**\n\n \n\nOur\ninsider trading policy has been adopted by our board of directors, governing the purchase, sale, and/or other dispositions of our securities\nby our directors, officers, and employees, to promote compliance with insider trading laws, rules and regulations, and Nasdaq listing\nstandards applicable to us, which was later amended in March 2025. In addition, it is the Company’s intent to comply with applicable\nlaws and regulations relating to insider trading. The latest version of our insider trading policy is filed as Exhibit 19.1 to this Form\n20-F.\n\n \n\n84"}